Industries > Pharma > Medical Device Contract Manufacturing: World Market Outlook 2013-2023

Medical Device Contract Manufacturing: World Market Outlook 2013-2023

PUBLISHED: 23 January 2013
PAGES: 125

WOOCS 2.2.1
SKU: N/A Categories: , ,

The medical device contract manufacturing market will witness significant growth during 2013-2023, driven by an expanding medical devices market. According to Visiongain estimates, the global medical devices market was worth $266.0bn in 2011. In the past, the medical device industry maintained a low level of outsourcing due to concerns over quality, delays and regulatory compliance. In recent years however, outsourcing has become more attractive, driven by the Original Equipment Manufacturers (OEMs) need to reduce costs and to accelerate the time to market. Contract manufacturers themselves have started to diversify their capabilities over the years and are able to offer a range of services, including design, engineering, packaging and distribution. The medical device contract manufacturing market was worth $33.6bn in 2011. It is estimated that outsourcing has allowed OEMs to reduce costs by 10-30%. More outsourcing companies are adopting the one stop-shop model to provide the entire range of outsourcing activities to OEMs. Overall, outsourcing allows OEMs to focus on their core competencies while delegating other non core activities to contract manufacturers.

In 2011, the US was the largest national market for contract manufacturing, accounting for 47.3% of the global market. However, Asian countries, particularly China and India are proving to be attractive low cost destinations for OEMs, witnessing a stronger growth rate compared to other developed countries. Additionally, with increasing cost pressures on OEMs which may intensify with the impending medical device excise tax, the offshoring of manufacturing to the CMOs based in low-cost destinations will become a strategic necessity. At present, the contract manufacturing market is highly fragmented with thousands of companies competing for a small share of the market. However, this may change significantly in the future with major consolidations within the industry.

Visiongain's updated report on Medical Device Contract Manufacturing 2013-2023 examines the medical devices and contract manufacturing market with respect to market size and sales forecasts from 2013-2023. It also discusses the detailed market forecasts for three main segments of contract manufacturing including material processing, electronics and finished products. The report discusses the estimates and projections for major geographical markets including the US, Germany, France, Italy, UK, Spain, Japan, China and India from 2013-2023. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interview with an expert within the medical device contract manufacturing market.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 – all highlighting key business opportunities.

Why you should buy Medical Device Contract Manufacturing: World Market Outlook 2013-2023

• 123 pages of comprehensive analysis
• 1 Exclusive Visiongain interview with experts from:
– Creganna-Tactx Medical
• 72 tables, charts, and graphs
• Medical device contract manufacturing market forecast between 2012-2023
• 3 medical device contract manufacturing submarket forecasts from 2012-2023
– Material Processing
– Electronic Manufacturing Services
– Finished Products
• A SWOT analysis
• Several leading companies identified and 6 profiled:
Accellent, Flextronics, Symmetry Medical, The Tech Group, Greatbach, Nortech Systems

You can order this report today

Gain an understanding of the overall medical device contract manufacturing market and the leading companies operating in this market by ordering Medical Device Contract Manufacturing: World Market Outlook 2013-2023.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Medical Device Contract Manufacturing: World Market Outlook 2013-2023

Download sample pages

Complete the form below to download your free sample pages for Medical Device Contract Manufacturing: World Market Outlook 2013-2023

Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021


Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021


Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021


Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021